Two-part Pricing for Patent-protected Medicines
Two-part Pricing for Patent-protected Medicines Poster presented at ISPOR International Meeting in Philadelphia, May 16-20, 2015 Many new medicines are targeting small patient populations. In order to recoup R&D costs, the medicines are highly priced. A dilemma is that the price per patient (or pill or vial) can be seen as blocking access. As the … Continued